Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study.

about

Impact of Conventional Medical Therapy on Bone Mineral Density and Bone Turnover in Adult Patients with X-Linked Hypophosphatemia: A 6-Year Prospective Cohort Study.

Item

http://www.wikidata.org/entity/Q48295533

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@en

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@nl

type

Item

label

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@en

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@nl

prefLabel

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@en

Impact of Conventional Medical ...... Year Prospective Cohort Study.

@nl

P1476

Impact of Conventional Medical ...... -Year Prospective Cohort Study

@en

P2093

Vikram Vinod Shanbhogue

http://www.w3.org/2001/XMLSchema#string

P2860

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

Regulation and function of the FGF23/klotho endocrine pathways

Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia

Effects of therapy in X-linked hypophosphatemic rickets

Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin.

Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis.

Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.

Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia.

Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.

New insights into the effects of primary hyperparathyroidism on the cortical and trabecular compartments of bone.

P2888

s00223-017-0363-3

P304

321-328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00223-017-0363-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Niklas Rye Jørgensen

Vikram V Shanbhogue

Stinus Hansen

Signe Sparre Beck-Nielsen

P577

2017-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29143140

http://www.w3.org/2001/XMLSchema#string